Media Centre
Latest press releases
-
Update on the Phase III EAGLE trial of Imfinzi and tremelimumab in advanced head and neck cancer
-
New long-term data on Calquence presented at ASH 2018
-
AstraZeneca presents clinical research advances for blood cancer patients at 2018 American Society of Hematology Annual Meeting
-
US FDA grants Fasenra Orphan Drug Designation for Eosinophilic Granulomatosis with Polyangiitis
-
AstraZeneca provides update on the Phase III MYSTIC trial of Imfinzi and tremelimumab in Stage IV non-small cell lung cancer
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
Contact us
Karen Birmingham
Director Global Science Media
Rob Skelding
Director Global Media Relations
Matthew Kent
Director Global Media Relations
Gonzalo Viña
Director Global Media Relations
Jennifer Hursit
Manager Global Media Relations
Jacob Lund
Director External Communications, Sweden
Lotta Sjösten
Manager Media Relations, Sweden
US Media Team
